ClinConnect ClinConnect Logo
Search / Trial NCT06464757

Laryngomalacia, Examinations and Quality of Life in Children Before and After Treatment With Follow-up After 1 Year

Launched by OSLO UNIVERSITY HOSPITAL · Jun 17, 2024

Trial Information

Current as of June 26, 2025

Recruiting

Keywords

ClinConnect Summary

This clinical trial is studying a common condition in infants called laryngomalacia, which can cause noisy breathing (stridor) and sometimes leads to breathing difficulties and sleep problems. The researchers want to find out if special sleep tests can help identify which children might benefit from surgery to improve their breathing. They will follow up with the children after a few weeks and again after a year to see how they are doing.

Eligible participants are children aged 7 days to 1 year who have laryngomalacia, show stridor, and have breathing difficulties. There are no exclusions based on other health conditions. If your child participates, they will undergo sleep examinations at home, and their quality of life will be assessed through a simple questionnaire. This study aims to use new technology, including artificial intelligence, to better understand the condition and its effects on children’s lives.

Gender

ALL

Eligibility criteria

  • Inclusion Criteria:
  • laryngomalacia
  • stridor
  • breathing difficulties
  • Exclusion Criteria:
  • - none

About Oslo University Hospital

Oslo University Hospital is a leading academic medical center in Norway, renowned for its commitment to advancing healthcare through innovative research and clinical trials. As a prominent sponsor of clinical studies, the hospital integrates cutting-edge scientific inquiry with patient care, fostering an environment that promotes the development of new therapies and treatment strategies. With a multidisciplinary approach, Oslo University Hospital collaborates with various stakeholders, including researchers, healthcare professionals, and industry partners, to enhance clinical outcomes and contribute to the global medical community. Its dedication to ethical standards and patient safety ensures that all trials are conducted with the highest level of integrity and respect for participant welfare.

Locations

Oslo, , Norway

Oslo, , Norway

Patients applied

0 patients applied

Timeline

First submit

Trial launched

Trial updated

Estimated completion

Not reported